Oracle CORP Form 4 insider transactions
NYSE
ORCL
Oracle CORPOracle's EVP and Principal Financial Officer, Douglas A. Kehring, sold 35,000 shares of common stock at $194.89 per share as part of a pre-arranged trading plan.
NYSE
ORCL
Oracle CORPOracle's President of Global Field Operations, Mark Hura, reported gifting 5,000 shares and selling 15,000 shares of common stock in late December.
NYSE
ORCL
Oracle CORPOracle Vice Chairman Jeffrey Henley reported a transfer of 199,071 common stock shares between his family trusts, a transaction exempt under SEC Rule 16a-13.
NYSE
ORCL
Oracle CORPOracle Director Naomi O. Seligman sold 2,223 shares of common stock for $196.61 per share under a pre-arranged 10b5-1 trading plan.
NYSE
ORCL
Oracle CORPOracle's Chief Executive Officer, Clayton M. Magouyrk, sold 10,000 shares of common stock for approximately $1.92 million under a pre-arranged trading plan.
NYSE
ORCL
Oracle CORPOracle's EVP, Chief Accounting Officer, Maria Smith, reported the vesting of restricted stock units and subsequent share disposition for tax purposes.
NYSE
ORCL
Oracle CORPOracle Director Stephen H. Rusckowski was granted 793 restricted stock units, vesting on the first anniversary of the grant date.
NYSE
ORCL
Oracle CORPOracle Director Jeffrey Berg sold 49,365 shares of common stock for approximately $13.5 million through pre-planned transactions.
NYSE
ORCL
Oracle CORPOracle's EVP and Principal Financial Officer, Douglas A. Kehring, was granted 60,700 restricted stock units, aligning executive interests with shareholder value.
NYSE
ORCL
Oracle CORPOracle's Executive Chairman and CTO, Lawrence J. Ellison, was granted 571,286 stock options with an exercise price of $280.07, vesting annually over four years.
NYSE
ORCL
Oracle CORPOracle's President of Global Field Operations, Mark Hura, was granted 428,465 stock options with an exercise price of $280.07, vesting annually over four years.
NYSE
ORCL
Oracle CORPOracle Corp. granted 32,135 restricted stock units to Vice Chairman Jeffrey Henley, aligning executive incentives with long-term shareholder value.
NYSE
ORCL
Oracle CORPOracle's Chief Executive Officer, Safra Catz, was granted 32,135 Restricted Stock Units, which will vest in four equal annual installments.
NYSE
ORCL
Oracle CORPOracle's EVP, Chief Accounting Officer, Maria Smith, was granted 35,706 restricted stock units, vesting over four years.
NYSE
ORCL
Oracle CORPOracle's EVP and Chief Legal Officer, Stuart Levey, acquired additional restricted stock units, including dividend equivalents and new grants, as part of his compensation.
NYSE
ORCL
Oracle CORPOracle's EVP, Chief Accounting Officer Maria Smith, sold 10,000 shares of common stock in two separate transactions under a pre-arranged Rule 10b5-1 trading plan.
NYSE
ORCL
Oracle CORPOracle's Chief Executive Officer, Clayton M. Magouyrk, sold 40,000 shares of common stock for approximately $11.06 million under a pre-arranged 10b5-1 trading plan.
NYSE
ORCL
Oracle CORPOracle's EVP and Chief Legal Officer, Stuart Levey, sold 19,758 shares of common stock for $300 per share under a pre-arranged 10b5-1 plan.
NYSE
ORCL
Oracle CORPOracle Director Naomi O. Seligman reported selling 2,222 shares and gifting 1,406 shares of common stock on September 26, 2025.
NYSE
ORCL
Oracle CORPOracle's Chief Executive Officer, Michael D. Sicilia, was granted 1,037,412 stock options with an exercise price of $308.46, vesting annually over four years.
NYSE
ORCL
Oracle CORPOracle CEO Clayton M. Magouyrk was granted 2,593,530 stock options with an exercise price of $308.46, vesting annually over four years.
NYSE
ORCL
Oracle CORPOracle President Michael Sicilia reported routine stock acquisitions and sales, including tax-related withholdings and planned dispositions under a 10b5-1 plan.
NYSE
ORCL
Oracle CORPOracle Vice Chairman Jeffrey Henley reported the vesting of restricted stock units and subsequent tax-related share dispositions.
NYSE
ORCL
Oracle CORPOracle's EVP, Chief Accounting Officer, Maria Smith, reported the vesting of restricted stock units into common stock and subsequent sales to cover tax liabilities.
NYSE
ORCL
Oracle CORPClayton M. Magouyrk, President of Oracle's OCI, exercised restricted stock units and subsequently sold a portion of the acquired shares to cover tax obligations.
NYSE
ORCL
Oracle CORPOracle's EVP, Chief Legal Officer, Stuart Levey, reported the vesting of restricted stock units and subsequent share disposition for tax obligations.
NYSE
ORCL
Oracle CORPOracle's EVP and Chief Accounting Officer, Maria Smith, reported the vesting and subsequent tax-related sale of company common stock.
NYSE
ORCL
Oracle CORPOracle's President of Industries, Michael D. Sicilia, reported the vesting of 52,673 restricted stock units, followed by tax-related share withholding and an open market sale of 16,323 common shares.
NYSE
ORCL
Oracle CORPOracle's EVP and Chief Legal Officer, Stuart Levey, reported the vesting of restricted stock units and a subsequent sale of shares to cover tax liabilities.
NYSE
ORCL
Oracle CORPOracle Vice Chairman Jeffrey Henley reported the vesting of restricted stock units and a subsequent tax-related sale of company common stock.